HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Colchicine treatment in a case of pachydermoperiostosis with acroosteolysis.

Abstract
We report a case of pachydermoperiostosis with arthralgia, acroosteolysis, and recurrent staphylococcal folliculitis of the face, treated with colchicine (0.5 mg once daily for the 1st week and 0.5 mg twice daily for the next 3 weeks). The evaluation of arthralgia, hyponchial angle, folliculitis, and pachyderma, performed at basal time and once weekly, showed improvement of symptoms and signs after 7-15 days of treatment. Neutrophilic chemotaxis, evaluated before starting the treatment and after 15 and 30 days of therapy, showed a progressive decrease of the initial very high index. Colchicine provided a beneficial therapeutic response in both inhibiting increased chemotactic activity and in reducing tissular oedema in our patient.
AuthorsM Matucci-Cerinic, L Fattorini, G Gerini, A Lombardi, A Pignone, N Petrini, T Lotti
JournalRheumatology international (Rheumatol Int) Vol. 8 Issue 4 Pg. 185-8 ( 1988) ISSN: 0172-8172 [Print] Germany
PMID3187331 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Colchicine
Topics
  • Adult
  • Chemotaxis (drug effects)
  • Colchicine (therapeutic use)
  • Fingers (diagnostic imaging)
  • Humans
  • Joints
  • Male
  • Osteoarthropathy, Primary Hypertrophic (complications, drug therapy)
  • Osteolysis (complications, diagnostic imaging, drug therapy)
  • Pain (complications, drug therapy)
  • Radiography
  • Skin Diseases (complications, drug therapy)
  • Toes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: